Astera Labs Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	723.04	396.29	115.79	79.87
Revenue Growth (YoY)	136.51%	242.24%	44.97%	-
Cost of Revenue	177.8	93.59	35.97	21.19
Gross Profit	545.23	302.7	79.83	58.68
Selling, General & Admin	171.9	217.94	35.92	45.16
Research & Development	266.73	200.83	73.41	73.71
Operating Expenses	438.63	418.77	109.32	118.88
Operating Income	106.61	-116.07	-29.5	-60.19
Interest & Investment Income	43.33	34.29	6.55	2.61
Pretax Income	149.94	-81.78	-22.95	-57.58
Income Tax Expense	-48.93	1.64	3.31	0.76
Net Income	198.87	-83.42	-26.26	-58.35
Net Income to Common	198.87	-83.42	-26.26	-58.35
Shares Outstanding (Basic)	164	131	37	34
Shares Outstanding (Diluted)	174	131	37	34
Shares Change (YoY)	72.70%	253.51%	8.66%	-
EPS (Basic)	1.21	-0.64	-0.71	-1.71
EPS (Diluted)	1.14	-0.64	-0.71	-1.71
Free Cash Flow	229.44	102.43	-15.48	-39.77
Free Cash Flow Per Share	1.32	0.78	-0.42	-1.16
Gross Margin	75.41%	76.38%	68.94%	73.47%
Operating Margin	14.74%	-29.29%	-25.47%	-75.36%
Profit Margin	27.50%	-21.05%	-22.68%	-73.05%
Free Cash Flow Margin	31.73%	25.85%	-13.37%	-49.79%
EBITDA	111.57	-112.91	-27.72	-59.39
EBITDA Margin	15.43%	-28.49%	-23.94%	-74.35%
D&A For EBITDA	4.96	3.15	1.78	0.81
EBIT	106.61	-116.07	-29.5	-60.19
EBIT Margin	14.74%	-29.29%	-25.47%	-75.36%

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q